Comparison of Pregnancy and Neonatal Outcomes of Single Frozen Blastocyst Transfer Between Letrozole-Induction and HRT Cycles in Patients With Abnormal Ovulation
- PMID: 33935972
- PMCID: PMC8087245
- DOI: 10.3389/fendo.2021.664072
Comparison of Pregnancy and Neonatal Outcomes of Single Frozen Blastocyst Transfer Between Letrozole-Induction and HRT Cycles in Patients With Abnormal Ovulation
Abstract
Background: The use of frozen embryo transfer (FET) cycles has dramatically risen. The optimal endometrial preparation method for women undergoing FET is of utmost importance to provide the optimal chances of pregnancy. For patients with abnormal ovulation in particular, there have been few studies on FET protocols; notably, most of these studies focus only on the clinical pregnancy rate or live birth rate (LBR) and pay little attention to the regimen's safety for offspring.
Methods: It was a retrospective cohort study. First FET cycle with a single blastocyst from whole embryo frozen IVF/ICSI at the Reproductive Center of Third Affiliated Hospital of Zhengzhou University between January 2016 and January 2020. The LBR was the primary outcome of interest. The secondary outcome measures were miscarriage rate and offspring safety, including preterm birth, low birthweight (LBW), small-for-gestational age (SGA), macrosomia and large-for-gestational age (LGA).
Results: In total, 2782 FET cycles met the eligibility criteria for analysis. Additionally, there were 1178 singleton births from FET cycles. The clinical pregnancy rate was 58.4% in the L-FET group and 54.5% in the HRT group, with no statistical significance (P=.116). The miscarriage rate was higher in the HRT group than in the L-FET group (21.7% vs. 14.3%, P=.005). The LBR was significantly higher in the L-FET group than in the HRT group (49.6% vs. 41.7%, P=.001). Neonatal outcomes were similar between the two groups. After adjustments for confounding factors, the LBR was higher in the L-FET group (aOR 1.30, 95% CI 1.06-1.58). The rate of miscarriage was lower in the L-FET group (aOR 0.63, 95% CI 0.44-0.90).
Conclusion: For patients with abnormal ovulation, the L-FET regimen has a higher LBR and lower miscarriage rate than HRT. The neonatal outcomes were similar between the two groups.
Keywords: frozen embryo transfer; letrozole; live birth rate; miscarriage; neonatal outcomes.
Copyright © 2021 Zhang, Li, Sun, Guan and Du.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Comparison of Perinatal Outcomes of Letrozole-Induced Ovulation and Hormone Replacement Therapy Protocols in Patients With Abnormal Ovulation Undergoing Frozen-Thawed Embryo Transfer: A Propensity Score Matching Analysis.Front Endocrinol (Lausanne). 2022 Mar 16;13:837731. doi: 10.3389/fendo.2022.837731. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35370976 Free PMC article.
-
Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome.Fertil Steril. 2019 Aug;112(2):371-377. doi: 10.1016/j.fertnstert.2019.04.014. Epub 2019 May 21. Fertil Steril. 2019. PMID: 31126712
-
Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer.Arch Gynecol Obstet. 2014 Mar;289(3):687-93. doi: 10.1007/s00404-013-3044-0. Epub 2013 Oct 10. Arch Gynecol Obstet. 2014. PMID: 24121690 Clinical Trial.
-
Immediate versus postponed frozen embryo transfer after IVF/ICSI: a systematic review and meta-analysis.Hum Reprod Update. 2021 Jun 22;27(4):623-642. doi: 10.1093/humupd/dmab002. Hum Reprod Update. 2021. PMID: 33594441
-
Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial preparation prior to frozen embryo transfer in women with polycystic ovary syndrome.Reprod Biol Endocrinol. 2022 Apr 2;20(1):62. doi: 10.1186/s12958-022-00931-4. Reprod Biol Endocrinol. 2022. PMID: 35366912 Free PMC article.
Cited by
-
Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study.Front Endocrinol (Lausanne). 2023 Jun 16;14:1156620. doi: 10.3389/fendo.2023.1156620. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37396165 Free PMC article.
-
The duration of estrogen treatment before progesterone application does not affect neonatal and perinatal outcomes in frozen embryo transfer cycles.Front Endocrinol (Lausanne). 2023 Jul 21;14:988398. doi: 10.3389/fendo.2023.988398. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37547302 Free PMC article.
-
Letrozole Supplementation and the Increased Risk of Elevated Progesterone Levels on Trigger Day.Front Endocrinol (Lausanne). 2022 Jul 25;13:904089. doi: 10.3389/fendo.2022.904089. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35957830 Free PMC article.
-
Comparison of Perinatal Outcomes of Letrozole-Induced Ovulation and Hormone Replacement Therapy Protocols in Patients With Abnormal Ovulation Undergoing Frozen-Thawed Embryo Transfer: A Propensity Score Matching Analysis.Front Endocrinol (Lausanne). 2022 Mar 16;13:837731. doi: 10.3389/fendo.2022.837731. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35370976 Free PMC article.
-
Scoping Review of Letrozole in Assisted Reproductive Cycles: Efficacy and Outcomes Across Infertility Causes.Healthcare (Basel). 2025 Jun 20;13(13):1486. doi: 10.3390/healthcare13131486. Healthcare (Basel). 2025. PMID: 40648511 Free PMC article. Review.
References
-
- Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. . Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update (2017) 23:139–55. 10.1093/humupd/dmw038 - DOI - PMC - PubMed
-
- De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, et al. . ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reproduct (2018) 33:1586–601. 10.1093/humrep/dey242 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous